Memantine (brand name Namenda) is an oral NMDA blocker that may be used to treat moderate to severe dementia in people with Alzheimer’s disease. Memantine is an NMDA (N-methyl-D …

Jun 11, 2024 · Memantine is commonly used to treat moderate to severe dementia related to Alzheimer’s disease. Memantine may also be used for other conditions as determined by your healthcare provider. How does...

Aug 9, 2024 · It comes in three forms: immediate-release tablet, oral solution, and extended-release capsule. Memantine is prescribed to treat moderate to severe dementia in adults with …

May 10, 2024 · It is used to treat dementia in people with Alzheimer's disease. What do I need to tell my doctor BEFORE I take Memantine Tablets? If you are allergic to this medicine (memantine tablets); any part of this medicine (memantine tablets); or any other drugs, foods, or substances. Tell your doctor about the allergy and what signs you had.

Memantine is a medication that comes in a tablet form. It treats dementia caused by Alzheimer’s disease. Dementia affects your thinking, memory, reasoning, personality, mood and behavior. …

Memantine is used to treat moderate to severe Alzheimer's disease. Memantine is not a cure for Alzheimer's disease but it can help people with the disease. Memantine will not cure Alzheimer's disease, and it will not stop the disease from getting worse. This medicine is available only with your doctor's prescription.

Memantine is a prescription drug used to treat moderate to severe confusion (dementia) related to Alzheimer's disease. It does not cure Alzheimer's disease, but it may improve memory, awareness, and the ability to perform daily functions.

Memantine is used to treat the symptoms of Alzheimer's disease (AD; a brain disease that slowly destroys the memory and the ability to think, learn, communicate and handle daily activities). Memantine is in a class of medications called NMDA receptor antagonists. It works by decreasing abnormal activity in the brain.

Feb 3, 2025 · Memantine hydrochloride tablets are an N-methyl-D-aspartate (NMDA) receptor antagonist indicated for the treatment of moderate to severe dementia of the Alzheimer’s type. (1) May be taken with or without food. (2) Initial dose is 5 mg once daily. Increase dose in 5 mg increments to a maintenance dose of 10 mg twice daily.

Dec 11, 2023 · Memantine hydrochloride tablets are indicated for the treatment of moderate to severe dementia of the Alzheimer’s type. The recommended starting dose of memantine hydrochloride tablets is 5 mg once daily. The dose should be increased in 5 mg increments to 10 mg/day (5 mg twice daily), 15 mg/day (5 mg and 10 mg as ...